Inventor profile of:

Jonathan Brazaitis

City:

Parlin, New Jersey

Country:

United States

Published Applications:

10

Last publication date:

2017-02-09

Top Assignees for applications by Jonathan Brazaitis

The entities that hold a legal rights for patent applications filed by inventor Brazaitis Jonathan:

Recent patent applications by Brazaitis Jonathan

Jonathan Brazaitis from Parlin, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2017-02-09
US20170038396A1
Physics

ELISA for a Naturally-Occurring Soluble Truncated Form of IL-23 Receptor

#2 | 2016-04-28
US20160115218A1
Chemistry; metallurgy

Anti-sense oligonucleotides targeted against exon 9 of IL-23R-alpha gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases

#3 | 2016-02-11
US20160039878A1
Chemistry; metallurgy

Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof

#4 | 2014-07-03
US20140187602A1
Chemistry; metallurgy

Anti-sense oligonucleotides targeted against exon 9 of IL-23Rα gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases

#5 | 2013-07-18
US20130183755A1
Chemistry; metallurgy

THERAPEUTIC APPLICATION OF ISOLATED NATURALLY-OCCURRING SOLUBLE TRUNCATED FORMS OF IL-23 RECEPTOR

#6 | 2013-07-04
US20130172272A1
Chemistry; metallurgy

Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof

#7 | 2013-02-07
US20130035365A1
Chemistry; metallurgy

Anti-sense oligonucleotides targeted against exon 9 of IL-23Rα gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases

#8 | 2013-01-31
US20130029907A1
Chemistry; metallurgy

Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof

#9 | 2012-07-05
US20120171704A1
Physics

Elisa for a naturally-occurring soluble truncated form of IL-23 receptor

#10 | 2012-03-22
US20120071422A1
Physics

Recombinant soluble truncated IL-23 receptor (IL-23R) capable of inhibiting IL-23R-mediated cell signaling

InventorID:

68175 āŽ˜